Pemphigus: all 76 studies
Page 1 of 1. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- Rituximab With Corticosteroids Versus Corticosteroids Plus Azathioprine for Moderate-to-Severe Pemphigus VulgarisNot yet recruitingNCT07769333Early Phase 1
- CD19 CAR-T Therapy for Refractory Pemphigus VulgarisRecruitingNCT07681388Not applicable
- Comparison of the Efficacy of Clobetasol Propionate 0.05% Mouthwash, Photobiomodulation, and Their Combination in Managing of Oral Lesions in Patient With Pemphigus Vulgaris.RecruitingNCT07641725Not applicable
- Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients.Not yet recruitingNCT06971172Not applicable
- A Single-center Study of CM313 in Patients With PemphigusNot yet recruitingNCT06904040Not applicable
- Impact of a Lifestyle Program on Quality of Life in Pemphigus PatientsNot yet recruitingNCT06901427Not applicable
- Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinical Study Supported by Immunological Evaluation.Not yet recruitingNCT06863454
- A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.Not yet recruitingNCT06663943Phase 1/2
- Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.RecruitingNCT06581562Phase 1
- A Clinical Study of B007 in the Treatment of Pemphigus.RecruitingNCT06454357Phase 2/3
- Coagulation Activation in Patients With PemphigusNot yet recruitingNCT06285435
- Evaluation of Galectin-3 in Serum and Saliva of Pemphigus PatientsNot yet recruitingNCT05992727
- FARD (RaDiCo Cohort) (RaDiCo-FARD)RecruitingNCT05954416
- Comparison of a Personalized Maintenance Therapy With the Standard Treatment in PemphigusRecruitingNCT05898308Phase 4
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesRecruitingNCT05635266
- Compassionate Use or Expanded Access of DupilumabAvailableNCT04776694
- A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)RecruitingNCT04422912Phase 1/2
- Autoimmune Blistering Diseases StudyRecruitingNCT02753777
- COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
- A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)TerminatedNCT04598477Phase 3Results posted
- A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)CompletedNCT04598451Phase 3Results posted
- Dexamethasone Solution and Dexamethasone in Mucolox™CompletedNCT04540133Phase 2Results posted
- A Study of PRN1008 in Patients With PemphigusTerminatedNCT03762265Phase 3Results posted
- Polyclonal Regulatory T Cells (PolyTregs) for PemphigusTerminatedNCT03239470Phase 1Results posted
- A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)TerminatedNCT03075904Phase 1/2Results posted
- A Study of PRN1008 in Adult Patients With Pemphigus VulgarisCompletedNCT02704429Phase 2Results posted
- Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus VulgarisTerminatedNCT02613910Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)CompletedNCT02383589Phase 3Results posted
- Study of Efficacy and Safety of VAY736 in Patients With Pemphigus VulgarisTerminatedNCT01930175Phase 2Results posted
- Efficacy and Safety of Ofatumumab in Treatment of Pemphigus VulgarisTerminatedNCT01920477Phase 3Results posted
- Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis PemphigusTerminatedNCT01313923Early Phase 1Results posted
- A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)CompletedNCT00683930Phase 3Results posted
- Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for PemphigusCompletedNCT00656656Phase 2Results posted
- Randomized Trial of IVIg With or Without Cyclophosphamide in PemphigusTerminatedNCT00483119Phase 2Results posted
- Use of Infliximab for the Treatment of Pemphigus VulgarisCompletedNCT00283712Phase 2Results posted
- Effect of Topical Insulin on Healing Rate of Pemphigus LesionsCompletedNCT07461103Phase 2
- Efficacy and Safety of Different Doses of Rituximab Therapy in Pemphigus PatientsCompletedNCT07457944
- Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and DermatologistsCompletedNCT07428915
- Periodontal Status and Disease Severity in Pemphigus Vulgaris PatientsCompletedNCT07384221
- A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral CenterActive, not recruitingNCT06949241
- Assessment of the 1-year Relapse Rate in Patients with Pemphigus Treated According to the Revised Pemphigus PNDSCompletedNCT06903494
- Comparing DCP and DAP for Pemphigus VulgarisCompletedNCT06846255Phase 4
- ONO-4059 Study in Patients With Steroid-resistant PemphigusActive, not recruitingNCT06696716Phase 3
- Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus VulgarisCompletedNCT06654817
- Identifying Factors Influencing In-Hospital Relapse in Pemphigus PatientsCompletedNCT06167408
- Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous PemphigoidStatus unknownNCT05594472Phase 3
- Validation of 5-Point Investigator Global Assessments for PemphigusStatus unknownNCT05534776
- Role of Tzanck Smear in Determining Pemphigus Vulgaris Disease ActivityStatus unknownNCT05338112
- A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)Status unknownNCT05303272Phase 4
- Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian PopulationStatus unknownNCT05284929
- IVIG With Rituximab vs Rituximab as First Line Treatment of PemphigusActive, not recruitingNCT04400994Phase 2
- Acquired Chronic Erosive Gingivitis: Clinical Relevance of Papillary Gingival BiopsyCompletedNCT04293718
- Phenotypic and Functional Characterisation of Human B-cell Response in PemphigusStatus unknownNCT04117529Not applicable
- Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris PatientsStatus unknownNCT04096222
- Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus VulgarisStatus unknownNCT04023149Phase 2
- A Study of the Safety and Tolerability of INCB050465 in Pemphigus VulgarisWithdrawnNCT03780166Phase 2
- A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With PemphigusCompletedNCT03334058Phase 2
- Serum IL-21 Levels in Patients With Pemphigus VulgarisStatus unknownNCT03177213
- Comparison Between Injections of Steroids and Autologous Platelet Rich Plasma in the Oral Erosions of Pemphigus VulgarisCompletedNCT02828163Phase 3
- Wound Dressings for Pemphigus and PemphigoidStatus unknownNCT02365675Not applicable
- Identification of Vulnerability Factors in the Course of Pemphigus PatientsCompletedNCT02237313Not applicable
- Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe PemphigusStatus unknownNCT01974518Phase 3
- Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous PemphigoidTerminatedNCT01559155
- Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via CylexStatus unknownNCT01338103Not applicable
- Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by RituximabCompletedNCT01299857Phase 3
- The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune DisordersCompletedNCT00960713
- Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With PemphigusCompletedNCT00784589Phase 3
- Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With PrednisoloneCompletedNCT00626678Phase 2
- Use of KC706 for the Treatment of Pemphigus VulgarisCompletedNCT00606749Phase 2
- Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus VulgarisTerminatedNCT00429533Phase 2
- Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin DisordersTerminatedNCT00278642Phase 1
- Effect of Anti CD20 in Pemphigus DeseaseCompletedNCT00213512Phase 2/3
- Study of Etanercept (Enbrel) in the Treatment of Pemphigus VulgarisCompletedNCT00135720Phase 2
- European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in PemphigusCompletedNCT00127764Phase 2/3
- Safety Study of PI-0824 to Treat Pemphigus VulgarisCompletedNCT00063752Phase 1
- Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory PemphigusCompletedNCT00010413Phase 2